These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


172 related items for PubMed ID: 15191678

  • 1. [Significance and expression of insulin-like growth factor 1 and IGF binding protein 3 in serum of patients with lung cancer].
    Wang H, Wan YX, Zhang QK.
    Ai Zheng; 2004 Jun; 23(6):710-4. PubMed ID: 15191678
    [Abstract] [Full Text] [Related]

  • 2. Analysis of insulin like growth factor 1 and insulin like growth factor binding protein 3 levels in bronchoalveolar lavage fluid and serum of patients with lung cancer.
    Unsal E, Köksal D, Yurdakul AS, Atikcan S, Cinaz P.
    Respir Med; 2005 May; 99(5):559-65. PubMed ID: 15823452
    [Abstract] [Full Text] [Related]

  • 3. Serum insulin-like growth factor (IGF) and IGF-binding protein levels and risk of lung cancer: a case-control study nested in the beta-Carotene and Retinol Efficacy Trial Cohort.
    Spitz MR, Barnett MJ, Goodman GE, Thornquist MD, Wu X, Pollak M.
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1413-8. PubMed ID: 12433720
    [Abstract] [Full Text] [Related]

  • 4. The prognostic significance of pretreatment plasma levels of insulin-like growth factor (IGF)-1, IGF-2, and IGF binding protein-3 in patients with advanced non-small cell lung cancer.
    Han JY, Choi BG, Choi JY, Lee SY, Ju SY.
    Lung Cancer; 2006 Nov; 54(2):227-34. PubMed ID: 16935391
    [Abstract] [Full Text] [Related]

  • 5. [A study on the relationship between insulin-like growth factor, insulin-like growth factor-binding protein-3 and fetal growth retardation].
    Zhang P, Liu B, Li G, Wu L, Yu M, Ou Y, Wang L.
    Zhonghua Fu Chan Ke Za Zhi; 2002 Feb; 37(2):65-8. PubMed ID: 11953064
    [Abstract] [Full Text] [Related]

  • 6. Putative role of serum insulin-like growth factor-1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels in the development of prostate cancer in Arab men.
    Kehinde EO, Akanji AO, Mojiminiyi OA, Bashir AA, Daar AS, Varghese R.
    Prostate Cancer Prostatic Dis; 2005 Feb; 8(1):84-90. PubMed ID: 15775992
    [Abstract] [Full Text] [Related]

  • 7. [Association of insulin, insulin-like growth factor and insulin-like growth factor binding proteins with the risk of colorectal cancer].
    Jiang B, Liu DB, Zhang X, DU LL, Han CZ.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2009 May; 12(3):264-8. PubMed ID: 19434535
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Insulin-like growth factor-binding protein-3 (IGFBP-3) but not insulin-like growth factor-I (IGF-I) remains elevated in euthyroid TSH-suppressed Graves' disease.
    Wan Nazaimoon WM, Khalid BA.
    Horm Metab Res; 1998 Apr; 30(4):213-6. PubMed ID: 9623636
    [Abstract] [Full Text] [Related]

  • 10. The role of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in human esophageal cancer.
    Sohda M, Kato H, Miyazaki T, Nakajima M, Fukuchi M, Manda R, Fukai Y, Masuda N, Kuwano H.
    Anticancer Res; 2004 Apr; 24(5A):3029-34. PubMed ID: 15517912
    [Abstract] [Full Text] [Related]

  • 11. Serum levels of IGF-I and IGFBP-III and their relation with carcinoembryonic antigen and carbohydrate antigen 19-9 in cases of esophageal cancer.
    Yilmaz O, Eroglu A, Dag E, Karaoglanoglu N, Yilmaz A.
    Int J Clin Pract; 2006 Dec; 60(12):1604-8. PubMed ID: 16704680
    [Abstract] [Full Text] [Related]

  • 12. Age-related serum levels of insulin-like growth factor-I, -II and IGF-binding protein-3 following myocardial infarction.
    Reeves I, Abribat T, Laramee P, Jasmin G, Brazeau P.
    Growth Horm IGF Res; 2000 Apr; 10(2):78-84. PubMed ID: 10931745
    [Abstract] [Full Text] [Related]

  • 13. Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions.
    Dinleyici EC, Kilic Z, Buyukkaragoz B, Ucar B, Alatas O, Aydogdu SD, Dogruel N.
    Neuro Endocrinol Lett; 2007 Jun; 28(3):279-83. PubMed ID: 17627262
    [Abstract] [Full Text] [Related]

  • 14. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P, Díez JJ, Fernández-Reyes MJ, Méndez J, Bajo MA, Aguilera A, Selgas R.
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [Abstract] [Full Text] [Related]

  • 15. Serum insulin-like growth factor binding protein-3/prostate-specific antigen ratio is a useful predictive marker in patients with advanced prostate cancer.
    Miyata Y, Sakai H, Hayashi T, Kanetake H.
    Prostate; 2003 Feb 01; 54(2):125-32. PubMed ID: 12497585
    [Abstract] [Full Text] [Related]

  • 16. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF, Odar-Cederlöf I, Ericsson F, Brismar K.
    Growth Regul; 1996 Sep 01; 6(3):137-43. PubMed ID: 8894646
    [Abstract] [Full Text] [Related]

  • 17. The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats.
    Frystyk J, Vinter-Jensen L, Skjaerbaek C, Flyvbjerg A.
    Growth Regul; 1996 Mar 01; 6(1):48-54. PubMed ID: 8717450
    [Abstract] [Full Text] [Related]

  • 18. [Analysis of serum insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 in benign prostatic hyperplasia].
    Yu JP, Wu XM, Chen JG, Liu WM, Yang QX.
    Zhonghua Nan Ke Xue; 2003 Aug 01; 9(5):341-3. PubMed ID: 14513639
    [Abstract] [Full Text] [Related]

  • 19. IGF-1 and IGFBP-3 in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G, Rapa A, Boccardo G, Silvestro L, Chiorboli E.
    Panminerva Med; 1998 Jun 01; 40(2):103-6. PubMed ID: 9689829
    [Abstract] [Full Text] [Related]

  • 20. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S, Vitelli G, Mirabelli R, Digiesu G, Giannarelli D, Cuneo A, Ribatti D, Vacca A.
    Eur J Haematol; 2006 Jan 01; 76(1):51-7. PubMed ID: 16343271
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.